Forward Pharma A/S: Forward Pharma A/S is a Danish biopharmaceutical company that commenced development in 2005 of a proprietary formulation of DMF for the treatment of inflammatory and neurological indications. The Company granted to Biogen an irrevocable license to all of its IP through the License Agreement and received from Biogen a non-refundable cash fee of $1.25 billion in February 2017, with the return of EUR 917.7 million to shareholders through a capital reduction in September 2017. The Company has the opportunity to receive royalties from Biogen on Biogen’s net sales of Tecfidera® or other DMF products for multiple sclerosis outside the U.S., dependent on, among other things, a favorable outcome in Europe with respect to the ‘355 Patent Opposition Proceeding, including any appeal thereto.
Sector/Industry:
Healthcare/Biotechnology
Characteristics:
Based in...
Europe
Disease Space
Central Nervous System
Finance
Pre-Revenues
Industry
Biotechnology, Life Sciences
Listing
Public, USA
Market Cap
<100MM
Therapeutic Modalities
Small Molecule
Website:
Address:
Østergade 24A, 1.
Copenhagen, 1100
Denmark

Company Participants at 2020 Wall Street "On Tap"

Claus Bo Svendsen, MD, PhD
Forward Pharma A/S, CEO
Dr. Svendsen has served as our Chief Executive Officer since March 2017. Within Forward Pharma, his previous role as Executive Vice President included responsibility for corporate functions, portfolio strategy, regulatory interactions and medical and scientific input across all phases of clinical trials. Prior to joining Forward Pharma in 2015, he held positions of increasing seniority in the Danish pharmaceutical company Novo Nordisk A/S, including roles of Global Medical Director for Victoza

Top 10 Holders of Forward Pharma A/S Sponsored ADR

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
BVF, Inc. 9.53 647,299 4.31 13F 6/30/20
Morgan Stanley Capital Services LLC 1.63 110,482 0.74 13F 6/30/20
Renaissance Technologies LLC 0.50 34,097 0.23 13F 6/30/20
Acadian Asset Management LLC 0.24 16,185 0.11 13F 6/30/20
Resources Investment Advisors LLC 0.21 14,083 0.09 13F 9/30/20
Securities America Advisors, Inc. 0.02 1,500 0.01 13F 6/30/20
Geode Capital Management LLC 0.01 499 0.00 Funds 8/31/20
UBS Group AG (13f Subfiler) 0.01 450 0.00 13F 6/30/20
Morgan Stanley Smith Barney LLC 0.00 17 0.00 13F 6/30/20
Vision2020 Wealth Management Corp. 0.00 1 0.00 13F 6/30/20
Ownership data is sourced through FactSet.

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.